Related Experiment Videos
Absence of circulating immune complexes containing DNA in hemodialysed sera
Summary
Researchers investigated DNA antibodies and immune complexes in dialysis patients. They found a low incidence of DNA antibodies, suggesting circulating DNA-anti-DNA complexes are not the cause in these patients.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Previous studies reported DNA and anti-DNA presence in hemodialysis patients.
- An improved detection technique was employed to re-evaluate these findings.
Purpose of the Study:
- To investigate the incidence of antibodies to single-stranded DNA (ss-DNA) and native DNA (n-DNA) in renal patients undergoing maintenance hemodialysis.
- To search for evidence of DNA-anti-DNA circulating immune complexes (CIC) formation in these patients.
Main Methods:
- Detection of antibodies to ss-DNA and n-DNA using an improved technique.
- Quantification of CICs using Raji-Raji-linked immunosorbent assay (RIA) and C1q-binding assay (BA).
- DNase digestion assays on patient sera and in vitro DNA-anti-DNA complexes.
Main Results:
- A low incidence of antibodies to n-DNA was observed in both dialysed (2/53) and non-dialysed (1/25) renal patients.
- Circulating immune complexes (CICs) were detected in 17/53 dialysed and 6/25 non-dialysed patients, with no significant difference between groups.
- DNase digestion did not significantly alter CIC levels in dialysed patients' sera, unlike in Systemic Lupus Erythematosus (SLE) sera or in vitro complexes.
Conclusions:
- The formation of circulating DNA-anti-DNA complexes does not appear to be the reason for the low incidence of antibodies to n-DNA in the sera of patients on maintenance hemodialysis.
- The improved detection technique revealed a lower prevalence of these antibodies than previously reported.